REDWOOD CITY, Calif., Feb. 10 /PRNewswire-FirstCall/ -- Genomic Health, Inc. today announced that Randy Scott, Ph.D., the Company’s Chairman and Chief Executive Officer will present at the 2006 BIO CEO & Investor Conference on Wednesday, February 15, 2006 at 10:00 a.m. Eastern at the Waldorf-Astoria in New York City.
To access the live and subsequently archived webcast of the presentation, visit the Investor Relations section of Genomic Health’s website at http://investor.genomichealth.com . Please connect to the web site at least 15 minutes prior to the call to allow for any necessary software downloads. An archived replay will be available for three months beginning 24 hours after the live presentation.
Later the same day, Genomic Health’s management team will preside over the Closing Bell ceremony at The Nasdaq Stock Market. The ceremony will be webcast live on Nasdaq’s website from 3:50 p.m. to 4:05 p.m. ET and on the Nasdaq Tower in Times Square. A video webcast of the ceremony will also be available via the Investor Relations section of Genomic Health’s web site.
About Genomic Health
Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched its first test, Oncotype DX(TM), which has been shown to predict the likelihood of breast cancer recurrence and chemotherapy benefit in early stage breast cancer patients. The company was founded in 2000 and is located in Redwood City, California. For more information, please visit www.genomichealth.com.
Genomic Health, Inc.
CONTACT: Brad Cole of Genomic Health, Inc., +1-650-569-2281, orinvestors@genomichealth.com; or media, Emily Faucette of WeissCommPartners, +1-415-946-1066, or emily@weisscommpartners.com, for GenomicHealth, Inc.
